Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers

Gabor Halmos, Attila Nagy, Najib Lamharzi, Andrew V Schally

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Recently, we developed two new cytotoxic analogs of luteinizing hormone-releasing hormone (LH-RH), AN-152 in which doxorubicin (DOX) is linked to [D-Lys6]LH-RH, and AN-207 which consists of 2-pyrrolino-DOX coupled to [D-Lys6]LH-RH. In this study, we examined binding of AN-152 and AN-207 to membranes of human breast cancer specimens and MCF-7 and MDA-MB-231 human breast cancer lines. Both cytotoxic analogs displayed IC50 values in the nanomolar concentration range (IC50=2-13 nM). Using radioligand binding studies, we characterized the receptors for LH-RH on membranes of breast cancers. In addition, the expression of mRNA for LH-RH receptors in MCF-7 and MDA-MB-231 cell lines was demonstrated by reverse transcription-polymerase chain reaction (RT-PCR). These highly active cytotoxic analogs of LH-RH have been designed as targeted chemotherapeutic agents for the treatment of various cancers expressing receptors for LH-RH. Copyright (C) 1999.

Original languageEnglish
Pages (from-to)129-136
Number of pages8
JournalCancer Letters
Volume136
Issue number2
DOIs
StatePublished - Mar 1 1999
Externally publishedYes

Fingerprint

LHRH Receptors
Gonadotropin-Releasing Hormone
Breast Neoplasms
Doxorubicin
Inhibitory Concentration 50
Membranes
Reverse Transcription
Cell Line
Polymerase Chain Reaction
Messenger RNA
Neoplasms
AN 207
lysine(6)-doxorubicin LHRH

Keywords

  • Breast cancer
  • LH-RH receptors
  • Targeted chemotherapeutic agents

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers. / Halmos, Gabor; Nagy, Attila; Lamharzi, Najib; Schally, Andrew V.

In: Cancer Letters, Vol. 136, No. 2, 01.03.1999, p. 129-136.

Research output: Contribution to journalArticle

Halmos, Gabor ; Nagy, Attila ; Lamharzi, Najib ; Schally, Andrew V. / Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers. In: Cancer Letters. 1999 ; Vol. 136, No. 2. pp. 129-136.
@article{ee1e76fa250d4069b123bdc952a05923,
title = "Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers",
abstract = "Recently, we developed two new cytotoxic analogs of luteinizing hormone-releasing hormone (LH-RH), AN-152 in which doxorubicin (DOX) is linked to [D-Lys6]LH-RH, and AN-207 which consists of 2-pyrrolino-DOX coupled to [D-Lys6]LH-RH. In this study, we examined binding of AN-152 and AN-207 to membranes of human breast cancer specimens and MCF-7 and MDA-MB-231 human breast cancer lines. Both cytotoxic analogs displayed IC50 values in the nanomolar concentration range (IC50=2-13 nM). Using radioligand binding studies, we characterized the receptors for LH-RH on membranes of breast cancers. In addition, the expression of mRNA for LH-RH receptors in MCF-7 and MDA-MB-231 cell lines was demonstrated by reverse transcription-polymerase chain reaction (RT-PCR). These highly active cytotoxic analogs of LH-RH have been designed as targeted chemotherapeutic agents for the treatment of various cancers expressing receptors for LH-RH. Copyright (C) 1999.",
keywords = "Breast cancer, LH-RH receptors, Targeted chemotherapeutic agents",
author = "Gabor Halmos and Attila Nagy and Najib Lamharzi and Schally, {Andrew V}",
year = "1999",
month = "3",
day = "1",
doi = "10.1016/S0304-3835(98)00316-4",
language = "English",
volume = "136",
pages = "129--136",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers

AU - Halmos, Gabor

AU - Nagy, Attila

AU - Lamharzi, Najib

AU - Schally, Andrew V

PY - 1999/3/1

Y1 - 1999/3/1

N2 - Recently, we developed two new cytotoxic analogs of luteinizing hormone-releasing hormone (LH-RH), AN-152 in which doxorubicin (DOX) is linked to [D-Lys6]LH-RH, and AN-207 which consists of 2-pyrrolino-DOX coupled to [D-Lys6]LH-RH. In this study, we examined binding of AN-152 and AN-207 to membranes of human breast cancer specimens and MCF-7 and MDA-MB-231 human breast cancer lines. Both cytotoxic analogs displayed IC50 values in the nanomolar concentration range (IC50=2-13 nM). Using radioligand binding studies, we characterized the receptors for LH-RH on membranes of breast cancers. In addition, the expression of mRNA for LH-RH receptors in MCF-7 and MDA-MB-231 cell lines was demonstrated by reverse transcription-polymerase chain reaction (RT-PCR). These highly active cytotoxic analogs of LH-RH have been designed as targeted chemotherapeutic agents for the treatment of various cancers expressing receptors for LH-RH. Copyright (C) 1999.

AB - Recently, we developed two new cytotoxic analogs of luteinizing hormone-releasing hormone (LH-RH), AN-152 in which doxorubicin (DOX) is linked to [D-Lys6]LH-RH, and AN-207 which consists of 2-pyrrolino-DOX coupled to [D-Lys6]LH-RH. In this study, we examined binding of AN-152 and AN-207 to membranes of human breast cancer specimens and MCF-7 and MDA-MB-231 human breast cancer lines. Both cytotoxic analogs displayed IC50 values in the nanomolar concentration range (IC50=2-13 nM). Using radioligand binding studies, we characterized the receptors for LH-RH on membranes of breast cancers. In addition, the expression of mRNA for LH-RH receptors in MCF-7 and MDA-MB-231 cell lines was demonstrated by reverse transcription-polymerase chain reaction (RT-PCR). These highly active cytotoxic analogs of LH-RH have been designed as targeted chemotherapeutic agents for the treatment of various cancers expressing receptors for LH-RH. Copyright (C) 1999.

KW - Breast cancer

KW - LH-RH receptors

KW - Targeted chemotherapeutic agents

UR - http://www.scopus.com/inward/record.url?scp=0032935902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032935902&partnerID=8YFLogxK

U2 - 10.1016/S0304-3835(98)00316-4

DO - 10.1016/S0304-3835(98)00316-4

M3 - Article

C2 - 10355741

AN - SCOPUS:0032935902

VL - 136

SP - 129

EP - 136

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -